PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.41%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.49B
AUM Growth
+$2.49B
(+15%)
Cap. Flow
+$216M
Cap. Flow
% of AUM
8.7%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
90
New
15
Increased
23
Reduced
16
Closed
9
Top Buys
| 1 |
Biogen
BIIB
|
$56.5M |
| 2 |
Stryker
SYK
|
$41.2M |
| 3 |
Icon
ICLR
|
$37.3M |
| 4 |
Alkermes
ALKS
|
$36M |
| 5 |
AbbVie
ABBV
|
$29M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$35.7M |
| 2 |
Avantor
AVTR
|
$28.6M |
| 3 |
uniQure
QURE
|
$23.5M |
| 4 |
Ascendis Pharma
ASND
|
$21.7M |
| 5 |
ICU Medical
ICUI
|
$20.2M |
Sector Composition
| 1 | Healthcare | 98.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
uniQure
QURE
$950M
| $695K | 0.03% |
60,617
-2,049,453
| -97% | -$23.5M |
|
77
Sana Biotechnology
SANA
$757M
| $83.2K | ﹤0.01% |
13,966
| – | – |
|
|
78
Ascendis Pharma
ASND
$12B
| – | – |
-202,115
| Closed | -$21.7M |
|
|
79
Avantor
AVTR
$8.76B
| – | – |
-1,351,326
| Closed | -$28.6M |
|
80
BioCryst Pharmaceuticals
BCRX
$1.73B
| – | – |
-2,162,411
| Closed | -$18M |
|
|
81
ICU Medical
ICUI
$3.04B
| – | – |
-122,703
| Closed | -$20.2M |
|
82
Outset Medical
OM
$242M
| – | – |
-324,982
| Closed | -$5.98M |
|
83
Invesco S&P 500 Equal Weight ETF
RSP
$73.3B
| – | – |
0
| – | – |
|
|
MRTX
84
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-318,948
| Closed | -$11.9M |
|
|
ISEE
85
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-1,465,483
| Closed | -$35.7M |
|
|
VECT
86
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| – | – |
-131,922
| Closed | -$1.12M |
|
|
BLU
87
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-439,813
| Closed | -$3.17M |
|